Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2016, Article ID 3702625, 10 pages
http://dx.doi.org/10.1155/2016/3702625
Research Article

Antibiotic Utilization Patterns in Patients with Ventilator-Associated Pneumonia: A Canadian Context

1Department of Pharmacy Services, Alberta Health Services-Calgary Zone, Calgary, AB, Canada
2Critical Care, Department of Pharmacy Services, Alberta Health Services-Calgary Zone, Calgary, AB, Canada
3Pediatrics, Department of Pharmacy Services, Alberta Health Services-Calgary Zone, Calgary, AB, Canada
4Departments of Critical Care Medicine and Medicine, Cumming School of Medicine, University of Calgary, Peter Lougheed Centre, Alberta Health Services-Calgary Zone, Calgary, AB, Canada

Received 11 June 2015; Accepted 13 November 2015

Copyright © 2016 Tracy Chin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Rewa and J. Muscedere, “Ventilator-associated pneumonia: update on etiology, prevention, and management,” Current Infectious Disease Reports, vol. 13, no. 3, pp. 287–295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. N. M. Joseph, S. Sistla, T. K. Dutta, A. S. Badhe, and S. C. Parija, “Ventilator-associated pneumonia: a review,” European Journal of Internal Medicine, vol. 21, no. 5, pp. 360–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. G. Muscedere, C. M. Martin, and D. K. Heyland, “The impact of ventilator-associated pneumonia on the Canadian health care system,” Journal of Critical Care, vol. 23, no. 1, pp. 5–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Rotstein, G. Evans, A. Born et al., “Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 19, no. 1, pp. 19–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Esmail, G. Duchscherer, J. Giesbrecht, J. King, P. Ritchie, and D. Zuege, “Prevention of ventilator-associated pneumonia in the calgary health region: a Canadian success story!,” Healthcare Quarterly, vol. 11, no. 3, pp. 129–136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. American Thoracic Society and Infectious Diseases Society of America, “Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 4, pp. 388–416, 2005. View at Publisher · View at Google Scholar
  7. J. Muscedere, P. Dodek, S. Keenan, R. Fowler, D. Cook, and D. Heyland, “Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: diagnosis and treatment,” Journal of Critical Care, vol. 23, no. 1, pp. 138–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. C. Horan, M. Andrus, and M. A. Dudeck, “CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting,” American Journal of Infection Control, vol. 36, no. 5, pp. 309–332, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Infection Prevention and Control and Department of Critical Care Medicine, “VAP Surveillance Program,” in Definitions, Alberta Health Services, Calgary, Canada, 2010, https://my.calgaryhealthregion.ca/http://iweb.calgaryhealthregion.ca/clin/icu/teams/vap/VapSurveillanceProgram.pdf. View at Google Scholar
  10. S. T. Micek, T. J. Heuring, J. M. Hollands, R. A. Shah, and M. H. Kollef, “Optimizing antibiotic treatment for ventilator-associated pneumonia,” Pharmacotherapy, vol. 26, no. 2, pp. 204–213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. T. Micek, S. Ward, V. J. Fraser, and M. H. Kollef, “A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia,” Chest, vol. 125, no. 5, pp. 1791–1799, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. M. H. Kollef, L. E. Morrow, M. S. Niederman et al., “Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia,” Chest, vol. 129, no. 5, pp. 1210–1218, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. N. Gilbert, R. C. Moellering Jr., G. M. Eliopoulos, H. F. Chambers, and M. S. Saag, Eds., The Sanford Guide to Antimicrobial Therapy, Antimicrobial Therapy, Sperryville, Va, USA, 2010.
  14. T. Mathevon, B. Souweine, O. Traoré, B. Aublet, and D. Caillaud, “ICU-acquired nosocomial infection: impact of delay of adequate antibiotic treatment,” Scandinavian Journal of Infectious Diseases, vol. 34, no. 11, pp. 831–835, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. C. M. Luna, P. Aruj, M. S. Niederman et al., “Appropriateness and delay to initiate therapy in ventilator-associated pneumonia,” European Respiratory Journal, vol. 27, no. 1, pp. 158–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Leone, F. Garcin, J. Bouvenot et al., “Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse,” Critical Care Medicine, vol. 35, no. 2, pp. 379–385, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. K. E. Kollef, G. E. Schramm, A. R. Wills, R. M. Reichley, S. T. Micek, and M. H. Kollef, “Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria,” Chest, vol. 134, no. 2, pp. 281–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. E. L. Kuti, A. A. Patel, and C. I. Coleman, “Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis,” Journal of Critical Care, vol. 23, no. 1, pp. 91–100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Chastre, M. Wolff, J.-Y. Fagon et al., “Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial,” Journal of the American Medical Association, vol. 290, no. 19, pp. 2588–2598, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. H. Kollef, P. Silver, D. M. Murphy, and E. Trovillion, “The effect of late-onset ventilator-associated pneumonia in determining patient mortality,” Chest, vol. 108, no. 6, pp. 1655–1662, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. Canadian Critical Care Trials Group, “A randomized trial of diagnostic techniques for ventilator-associated pneumonia,” The New England Journal of Medicine, vol. 355, no. 25, pp. 2619–2630, 2006. View at Google Scholar
  22. A. Kumar, D. Roberts, K. E. Wood et al., “Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock,” Critical Care Medicine, vol. 34, no. 6, pp. 1589–1596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Iregui, S. Ward, G. Sherman, V. J. Fraser, and M. H. Kollef, “Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia,” Chest, vol. 122, no. 1, pp. 262–268, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. D. H. Kett, E. Cano, A. A. Quartin et al., “Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study,” The Lancet Infectious Diseases, vol. 11, no. 3, pp. 181–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Garnacho-Montero, M. Sa-Borges, J. Sole-Violan et al., “Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy,” Critical Care Medicine, vol. 35, no. 8, pp. 1888–1895, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Sakaguchi, N. Shime, N. Iguchi, A. Kobayashi, K. Takada, and L. E. Morrow, “Effects of adherence to ventilator-associated pneumonia treatment guidelines on clinical outcomes,” Journal of Infection and Chemotherapy, vol. 19, no. 4, pp. 599–606, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Chastre and J.-Y. Fagon, “Ventilator-associated pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 7, pp. 867–903, 2002. View at Publisher · View at Google Scholar · View at Scopus